Kushner RF, Ryan DH, Deanfield J, Kokkinos A, Cercato C, Wilding J, Burguera B, Wu CC, Craciun AE, Pall D, Hramiak I, Hjelmesth J, Harder-Lauridsen NM, Weimers P, Jeppesen OK, Kallenbach K, Lincoff AM, Lingvay I
Tablet-based weight loss treatments Contain a GLP-1 receptor agonist (the same active ingredient as Wegovy) Taken once daily orally, rather than once weekly by injection Clinically tested with results comparable to injectable options A non-injectable alternative for those who prefer not to use a pen Easier to fit into everyday life for some people No refrigeration or injection equipment required The same clinically-led approach, in a simpler format Oral GLP-1 tablets and injectable GLP-1 treatments are both effective, clinically-proven options
Feel free to switch up the type of movement youre doing to keep things fresh
Follow-up Re-check metabolic markers and IGF-1 after 6-8 weeks, with earlier review if GI symptoms, glucose symptoms, or fluid retention occur